Fundz

Coeptis Therapeutics Holdings reported raising $4.3 Million in an initial SEC Form D filing, from an offering of $10 Million

PRIVATEJun 27, 2024$4.3M of $10M raised

Amount Raised

$4.3 Million

$4.3 Million sold, per SEC Form D (first sale Jun 14, 2024)

Round Type

Venture

WexfordHealthcareHealth Care

Quick answer

Coeptis Therapeutics raised $4.3 Million in a funding round, dated June 14, 2024. Coeptis Therapeutics is based in Wexford, Pennsylvania, United States.

How much did Coeptis Therapeutics raise?
Coeptis Therapeutics raised $4.3 Million in a funding round on June 14, 2024.
What does Coeptis Therapeutics do?
Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP) is a biopharmaceutical company developing innovative cell therapy platforms for patients with cancer.
Where is Coeptis Therapeutics based and how big is it?
Coeptis Therapeutics is based in Wexford, Pennsylvania, United States.
Who are the decision-makers at Coeptis Therapeutics?
Fundz holds 1 contact at Coeptis Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Health Care around the same time

Companies in the same sectors as Coeptis Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Hummingbird Healthcare raised $1.1M on May 29, 2024.
  • Hummingbird Healthcare raised $9.9M on May 29, 2024.
  • Otolith Labs raised $4.9M (Series A) on July 29, 2024.
  • CEL-SCI Corporation raised $11M (Debt Financing) on July 29, 2024.
  • Clarapath raised $36M (Series B) on July 24, 2024.
  • Pelthos Therapeutics raised $750K on July 24, 2024.

Who to call at Coeptis Therapeutics, and when

A new round usually means Coeptis Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Coeptis Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Coeptis Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Coeptis Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Coeptis Therapeutics

Location

105 BRADFORD ROAD

Wexford, Pennsylvania, United States

About

Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP) is a biopharmaceutical company developing innovative cell therapy platforms for patients with cancer.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Coeptis Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts4 people are listed at Coeptis Therapeutics. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Coeptis Therapeutics's next move

See what Strategic adds

Coeptis Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.